CA Patent

CA2637931A1 — Chemically modified polycation polymer for sirna delivery

Assigned to Abbott Laboratories · Expires 2007-07-26 · 19y expired

What this patent protects

The present invention provides a unique non-viral carrier for nucleic acid delivery in vitro and in vivo, and methods of using thereof.

USPTO Abstract

The present invention provides a unique non-viral carrier for nucleic acid delivery in vitro and in vivo, and methods of using thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA2637931A1
Jurisdiction
CA
Classification
—
Expires
2007-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.